Covid-19 roundup: Moderna kicks off trial for Omicron-specific vaccine; EMA signs off on Pfizer pill

Amber Tong

Zachary Brennan

Senior Editor

Just a day after Pfizer and BioNTech announced the start of trials for their Omicron-specific vaccine booster candidate, Moderna put out word that it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Moderna kicks off trial for Omicron-specific vaccine; EMA signs off on Pfizer pill

Amber Tong

Zachary Brennan

Senior Editor

Sign up to read this article for free.

After stock slides, Amgen addresses bone density talk on obesity drug

Danish biotech Gubra touts early weight loss data in hot amylin field

J&J takes 340B fight with federal government to court

New cancer class heats up as BioNTech buys out China partner and its PD-L1/VEGF drug

Exclusive: Flagship names two CEO-partners to lead Valo Health, Apriori Bio

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?

Covid-19 roundup: Mod­er­na kicks off tri­al for Omi­cron-spe­cif­ic vac­cine; EMA signs off on Pfiz­er pill

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Moderna kicks off trial for Omicron-specific vaccine; EMA signs off on Pfizer pill